CG Oncology, Inc. (CGON) Executive Compensation
CG Oncology, Inc. (CGON) is a publicly traded company on the Nasdaq, categorized under SIC 2836 (Biological Products, (No Diagnostic Substances)). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: CGON
CIK: 1991792
Exchange: Nasdaq
SIC 2836: Biological Products, (No Diagnostic Substances)
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 12/31/2022 12:00:00 AM
Lead Engagement PartnerMary Garrett
Audit LocationIrvine, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 144 | 2026-10-15 | — | 144 Filing | 0001950047-26-010274 | View SEC Doc Filr Page |
| 144 | 2026-09-21 | — | 144 Filing | 0001950047-26-009691 | View SEC Doc Filr Page |
| 144 | 2026-09-17 | — | 144 Filing | 0001950047-26-009639 | View SEC Doc Filr Page |
| 4 | 2026-09-17 | 2026-09-15 | 4 | 0001193125-26-394394 | View SEC Doc Filr Page |
| 144 | 2026-09-11 | — | 144 Filing | 0001950047-26-009375 | View SEC Doc Filr Page |
| 144 | 2026-09-02 | — | 144 Filing | 0001950047-26-009036 | View SEC Doc Filr Page |
| 144 | 2026-08-31 | — | 144 Filing | 0001950047-26-008873 | View SEC Doc Filr Page |
| 144 | 2026-08-27 | — | 144 Filing | 0001950047-26-008793 | View SEC Doc Filr Page |
| 144 | 2026-08-25 | — | 144 Filing | 0001950047-26-008678 | View SEC Doc Filr Page |
| 144 | 2026-08-24 | — | 144 Filing | 0001950047-26-008634 | View SEC Doc Filr Page |
| 144 | 2026-08-19 | — | 144 Filing | 0001950047-26-008371 | View SEC Doc Filr Page |
| 4 | 2026-08-18 | 2026-08-14 | 4 | 0001193125-26-355561 | View SEC Doc Filr Page |
| 144 | 2026-08-17 | — | 144 Filing | 0001950047-26-008205 | View SEC Doc Filr Page |
| 144 | 2026-08-14 | — | 144 Filing | 0001950047-26-008191 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001104659-26-097055 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001493215-26-000147 | View SEC Doc Filr Page |
| 144 | 2026-08-13 | — | 144 Filing | 0001950047-26-008109 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-13 | — | SCHEDULE 13G/A Filing | 0000902219-26-000242 | View SEC Doc Filr Page |
| 144 | 2026-08-12 | — | 144 Filing | 0001950047-26-008043 | View SEC Doc Filr Page |
| 144 | 2026-08-11 | — | 144 Filing | 0001950047-26-007989 | View SEC Doc Filr Page |
| 144 | 2026-08-10 | — | 144 Filing | 0001950047-26-007845 | View SEC Doc Filr Page |
| 144 | 2026-08-07 | — | 144 Filing | 0001950047-26-007823 | View SEC Doc Filr Page |
| 144 | 2026-08-06 | — | 144 Filing | 0001950047-26-007736 | View SEC Doc Filr Page |
| 10-Q | 2026-08-06 | 2026-06-30 | 10-Q | 0001193125-26-336918 | View SEC Doc Filr Page |
| 8-K | 2026-08-06 | 2026-08-06 | 8-K | 0001193125-26-336886 | View SEC Doc Filr Page |